Ativo Capital Management’s Advantest Corp ATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.84M Buy
13,637
+1,711
+14% +$356K 2.17% 9
2026
Q1
$1.62M Buy
11,926
+26
+0.2% +$3.53K 1.41% 33
2025
Q4
$1.5M Buy
+11,900
New +$1.5M 1.32% 37
2024
Q2
– Sell
-33,600
Closed -$1.5M – 53
2024
Q1
$1.5M Sell
33,600
-15,400
-31% -$687K 1.5% 20
2023
Q4
$1.65M Buy
49,000
+36,650
+297% +$1.24M 1.77% 12
2023
Q3
$1.38M Sell
12,350
-200
-2% -$22.4K 1.56% 16
2023
Q2
$1.69M Sell
12,550
-4,450
-26% -$598K 1.78% 13
2023
Q1
$1.58M Buy
+17,000
New +$1.58M 1.93% 13

Other funds holding ATE

Ativo Capital Management's ATE Position: Q2 2026 in Review

Ativo Capital Management increased its Advantest Corp (ATE) stake by 14% in Q2 2026, buying an estimated $356K and bringing the position to 13,637 shares worth $2.84M. The position accounts for 2.17% of the portfolio, ranked #9.

Ativo Capital Management first reported a position in ATE in Q1 2023 and has held it in 8 quarters since. 18 funds tracked by Wall St. Rank hold ATE as of Q2 2026.

  • Ativo Capital Management held 13,637 shares of Advantest Corp worth $2.84M as of Q2 2026.
  • Ativo Capital Management bought 1,711 Advantest Corp shares in Q2 2026, an estimated $356K.
  • Advantest Corp made up 2.17% of Ativo Capital Management's portfolio in Q2 2026, its #9 holding.
  • Ativo Capital Management first reported a position in Advantest Corp in Q1 2023 and has held it in 8 quarters since.
  • 18 funds tracked by Wall St. Rank held Advantest Corp as of Q2 2026.

Based on Ativo Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.